0 (0%) | 03-29 00:54 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 270.61 | 1-year : | 316.07 |
Resists | First : | 231.69 | Second : | 270.61 |
Pivot price | 223.96 | |||
Supports | First : | 220.29 | Second : | 213.25 |
MAs | MA(5) : | 226.37 | MA(20) : | 222.85 |
MA(100) : | 192.45 | MA(250) : | 173.05 | |
MACD | MACD : | 4.2 | Signal : | 4.4 |
%K %D | K(14,3) : | 65 | D(3) : | 62 |
RSI | RSI(14): 65.5 | |||
52-week | High : | 231.69 | Low : | 140.91 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AXP ] has closed below upper band by 20.9%. Bollinger Bands are 29.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 228.99 - 230.12 | 230.12 - 231.03 |
Low: | 223.17 - 224.73 | 224.73 - 225.99 |
Close: | 225.52 - 227.87 | 227.87 - 229.77 |
Tue, 26 Mar 2024
Imagine Owning Aquinox Pharmaceuticals (NASDAQ:AQXP) While The Price Tanked 68% - Yahoo Movies Canada
Thu, 08 Jun 2017
Allergan to Buy Keller Funnel, Boost Plastic Surgery Unit - Yahoo Finance
Thu, 24 Nov 2016
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 - Insider Monkey
Fri, 14 Aug 2015
How This Biotech Stock Gained Over 3,000% and Trapped Investors - Money Morning
Tue, 11 Aug 2015
This stock is up more than 1,000% in the past 3 days - CNN
Fri, 07 Mar 2014
Aquinox Pharmaceuticals Prices Initial Public Offering - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 720 (M) |
Shares Float | 570 (M) |
Held by Insiders | 21 (%) |
Held by Institutions | 65.2 (%) |
Shares Short | 8,320 (K) |
Shares Short P.Month | 8,070 (K) |
EPS | 11.21 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 38.81 |
Profit Margin | 15 % |
Operating Margin | 17.3 % |
Return on Assets (ttm) | 3.4 % |
Return on Equity (ttm) | 31.7 % |
Qtrly Rev. Growth | 9.1 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 77.2 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 26.2 % |
Operating Cash Flow | 18,560 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 20.31 |
PEG Ratio | 1.2 |
Price to Book value | 5.86 |
Price to Sales | 2.94 |
Price to Cash Flow | 8.83 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |